Siddha Medicine: What Research Shows by Specific Use

The big picture

Proper evidence not found for Siddha overall. We searched PubMed for systematic reviews, randomized trials and safety reports about Siddha and found trials of a few formulas, many small case reports and several protocols for trials still in progress. A 2026 Singapore case review says there has been limited scientific evidence of effectiveness for the traditional Indian systems. [1] Many Siddha studies come from government Siddha research bodies, which is worth knowing when you weigh them.

Evidence by specific use

1. Mild to moderate COVID-19 (added to usual care)

   Promising but limited

   Shorter hospital stay, lower viral load and faster symptom clearance than placebo; two minor adverse events recorded. [2]

   What was studied: Two decoctions, Nilavembu Kudineer and Kabasura Kudineer, vs placebo tea; 125 people, double-blind

2. Symptom-free COVID-19 infection

   Promising but limited

   Greater fall in viral load by day 7; no one became symptomatic; no adverse effects seen. Larger trials called for. [3]

   What was studied: Kabasura Kudineer vs vitamin C and zinc; open-label, one center

3. COVID-19, all Indian traditional systems

   Mixed

   Studies varied too widely to be definitive; about half of randomized trials were at low-to-moderate risk of bias. [4]

   What was studied: Evidence map of 304 studies, 22 of them Siddha

4. Neck pain (cervical spondylosis), varmam

   Insufficient evidence

   Pain and disability scores fell; authors say further studies are needed. [5]

   What was studied: 10 people, 12 sessions, no control group

5. Psoriasis, Indian traditional systems including Siddha

   Insufficient evidence

   All reported improvement, but designs and outcome measures were too uneven to conclude effectiveness. [6]

   What was studied: Review of 17 studies

6. Diabetes, arthritis, skin disease and other chronic conditions

   Traditional use only

   A practitioner-authored review says Siddha has safe treatment for psoriasis, eczema and other conditions. [7] We found no trials that support those claims.

   What was studied: Practitioner and institutional descriptions

Reading the COVID-19 trials carefully

The two decoction trials were small, ran about a week to ten days and measured lab and hospital outcomes. In the placebo-controlled trial, the decoctions were added to standard care. [2] The open-label trial compared the decoction with vitamin C and zinc rather than a placebo, so people and clinicians knew who got what. [3] The authors of both trials are from Siddha research bodies and hospitals. Neither trial tells us whether Siddha products are safe or useful for other people, other infections or long-term use.

Government research bodies

The Ministry of AYUSH dossier says the Central Council for Research in Siddha is an apex research body that sets standards for research methods and works on safety and efficacy of Siddha drugs. [9] That describes intent. Published trials are what matter for weighing benefit.

Sensible use

Do not use a Siddha product to replace treatment for infection, diabetes, cancer, heart disease or any serious illness. Tell your clinician about everything you take. [10] See Siddha medicine overview, varmam and does traditional medicine work.